Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 13 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen How who wrote (808)	4/1/1998 12:19:00 PM
From: Jim Roof	Read Replies (2) of 1432

I say it is positive news because some short traders were even doubting whether Biotime had the resources to file for an NDA. I do not know what their evaluation was based upon but I do know that not every thing they say is a valid concern. You know that many were saying just a few weeks ago that 95% of new applications get turned down and therefore BTIM's chances of approval were 5%. You know that's a very unrealistic view. I have no estimate of the sales figures. I would need to know the total hetastarch sales of last year before I would even guess. The problem is that nobody has a clue as to what these actual figures are. Some say 200M and others say 25M. Do you have accurate data on this? I am basing my stance on the number of high blood loss surgeries and the number of liters of blood lost in these procedures. I am coupling to this the fact that a caregiver/hospital could be held liable if they did not provide the best care for surgery patients. If Hextend proves to be a safer product then I think it will be quickly integrated into the market. Why do you think fast track is unlikely? Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next